We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$60.8B
1-Year Est. Return
42.06%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
–
AUM
$49.3B
AUM Growth
+$3.1B
(+6.7%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.5M |
| 2 |
NVIDIA
NVDA
|
+$75.6M |
| 3 |
Eli Lilly
LLY
|
+$70.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$58.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$55.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$107M |
| 2 |
Pfizer
PFE
|
+$70M |
| 3 |
Johnson & Johnson
JNJ
|
+$68M |
| 4 |
Danaher
DHR
|
+$56.4M |
| 5 |
Walmart Inc
WMT
|
+$54.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Healthcare | 17.5% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
DuPont de Nemours
DD
$17.8B
| $95.5M | 0.19% |
1,065,340
+64,070
| +6% | +$5.51M |
|
102
Biogen
BIIB
$32.6B
| $95.5M | 0.19% |
335,308
+6,915
| +2% | +$2.06M |
|
103
American Express
AXP
$220B
| $95.2M | 0.19% |
546,660
+46,320
| +9% | +$7.47M |
|
104
McKesson
MCK
$106B
| $94.7M | 0.19% |
221,534
-20,733
| -9% | -$7.97M |
|
105
Marvell Technology
MRVL
$201B
| $93.4M | 0.19% |
1,561,956
-30,504
| -2% | -$1.48M |
|
106
Monolithic Power Systems
MPWR
$60.1B
| $92.6M | 0.19% |
171,426
+14,268
| +9% | +$6.78M |
|
|
WNS
107
DELISTED
WNS Holdings
WNS
| $89.9M | 0.18% |
1,219,344
+292,131
| +32% | +$23.4M |
|
108
EOG Resources
EOG
$76.2B
| $89.6M | 0.18% |
783,338
-27,764
| -3% | -$3.17M |
|
|
109
Regeneron Pharmaceuticals
REGN
$85.2B
| $89.6M | 0.18% |
124,653
+76,094
| +157% | +$58.7M |
|
110
iShares MSCI India ETF
INDA
$6.77B
| $89.1M | 0.18% |
2,040,030
+15,629
| +0.8% | +$647K |
|
111
Pool Corp
POOL
$6.73B
| $88.7M | 0.18% |
236,751
+107,433
| +83% | +$36.7M |
|
112
Blackstone
BX
$102B
| $88.5M | 0.18% |
951,676
+89,053
| +10% | +$7.69M |
|
113
Church & Dwight Co
CHD
$23.4B
| $85.9M | 0.17% |
857,230
+18,706
| +2% | +$1.76M |
|
114
Apollo Global Management
APO
$78.9B
| $85.8M | 0.17% |
1,117,360
-143,949
| -11% | -$9.63M |
|
115
Workday
WDAY
$47.2B
| $84.8M | 0.17% |
375,197
-83,694
| -18% | -$16.8M |
|
116
Amgen
AMGN
$236B
| $83.4M | 0.17% |
375,469
-19,028
| -5% | -$4.42M |
|
117
iShares Core S&P 500 ETF
IVV
$875B
| $82.4M | 0.17% |
184,810
-84,743
| -31% | -$35.7M |
|
118
Wabtec
WAB
$47.8B
| $81.4M | 0.17% |
742,646
-88,280
| -11% | -$8.76M |
|
119
Boston Scientific
BSX
$69.3B
| $78.8M | 0.16% |
1,457,243
-206,574
| -12% | -$10.8M |
|
120
Oneok
OKE
$60.2B
| $78.4M | 0.16% |
1,270,221
+15,772
| +1% | +$976K |
|
121
Henry Schein
HSIC
$10B
| $78.1M | 0.16% |
962,409
+555,218
| +136% | +$43.9M |
|
122
Roper Technologies
ROP
$40.3B
| $77.6M | 0.16% |
161,400
-8,612
| -5% | -$3.9M |
|
123
Intel
INTC
$506B
| $77.4M | 0.16% |
2,313,772
-722,599
| -24% | -$22.7M |
|
124
Equitable Holdings
EQH
$14.4B
| $76.9M | 0.16% |
2,831,012
+317,348
| +13% | +$8.03M |
|
125
Motorola Solutions
MSI
$77.5B
| $76.3M | 0.15% |
260,076
-1,160
| -0.4% | -$332K |
|
Similar funds
Ensign Peak Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
- Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
- Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
- Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
- Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.
Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.